妇科癌症风险因子宫内膜异位症类型而异
基于芬兰医院出院登记(1987-2012年)中49,933例子宫内膜异位症女性的人群研究,按卵巢型、腹膜型、深部浸润型分别分析妇科癌症风险。卵巢子宫内膜异位症与卵巢癌风险升高相关(标准化发病比1.76),尤其子宫内膜样和透明细胞组织学类型;腹膜型和深部浸润型整体卵巢癌风险未升高。结论指出每1000例随访10年卵巢子宫内膜异位症患者中额外增加2例卵巢癌。
要点
- 卵巢子宫内膜异位症患者卵巢癌风险升高(标准化发病比1.76,95%CI 1.47-2.08)。
- 卵巢子宫内膜异位症中子宫内膜样癌(4.72)和透明细胞癌(10.1)风险最高,多发生于术后5-10年。
- 腹膜型和深部浸润型子宫内膜异位症整体卵巢癌风险未升高。
核心结论
- 卵巢子宫内膜异位症女性卵巢癌超额风险相当于每1000例随访10年额外增加2例。
- 在规划子宫内膜异位症女性长期管理时认识这些风险很重要。
研究设计与样本
- 基于芬兰医院出院登记(1987-2012年)手术确诊子宫内膜异位症的女性人群研究,共49,933例。
- 亚型分析包括卵巢型(n=23,210)、腹膜型(n=20,187)和深部浸润型(n=2,372)。
- 妇科癌症来自芬兰癌症登记,随访838,685人年,以芬兰女性人群为参照。
- 结局指标为标准化发病比(95%CI),按组织学、术后随访时间和随访时年龄分层。
主要发现
- 子宫内膜异位症与卵巢癌风险升高相关(标准化发病比1.76,95%CI 1.47-2.08)。
- 卵巢癌组织学类型中,子宫内膜样癌标准化发病比3.12(95%CI 2.15-4.38),透明细胞癌5.17(95%CI 3.20-7.89),浆液性癌1.37(95%CI 1.02-1.80)。
- 卵巢子宫内膜异位症患者卵巢癌风险最高,子宫内膜样癌标准化发病比4.72(95%CI 2.75-7.56),透明细胞癌10.1(95%CI 5.50-16.9),多发生于索引手术后5-10年。
- 腹膜型和深部浸润型子宫内膜异位症整体卵巢癌风险未升高;但腹膜型子宫内膜异位症与子宫内膜样组织学风险增加两倍相关。
- 整个队列子宫内膜癌风险未改变;癌前宫颈病变标准化发病比0.81(95%CI 0.71-0.92),宫颈浸润性鳞状细胞癌0.46(95%CI 0.20-0.91)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the risks of gynecologic cancer according to the type of endometriosis in women with surgically verified endometriosis. METHODS: This is a population-based study of women with surgically verified endometriosis retrieved from the Finnish Hospital Discharge Register 1987-2012 (N=49,933); the subtypes of ovarian (n=23,210), peritoneal (n=20,187), and deep infiltrating (n=2,372) endometriosis were analyzed separately. Gynecologic cancers were obtained from the Finnish Cancer Registry. The outcome measure was the standardized incidence ratio (95% CI) calculated as the ratio between the observed to the expected number of cancers and defined for each gynecologic cancer and further stratified according to the histology, follow-up time since surgery, and age at follow-up. The follow-up was 838,685 person-years, and the Finnish female population served as the reference. RESULTS: Endometriosis was associated with increased risk of ovarian cancer (standardized incidence ratio 1.76 [95% CI 1.47-2.08]), especially with endometrioid (3.12 [2.15-4.38]) and clear cell (5.17 [3.20-7.89]) histologic type and to a lesser extent with serous type (1.37 [1.02-1.80]). The risk of ovarian cancer was highest among women with ovarian endometriosis and especially for endometrioid (4.72 [2.75-7.56]) and clear cell (10.1 [5.50-16.9]) ovarian cancer, occurring 5-10 years after the index surgery. The overall risk of ovarian cancer was not increased among women with peritoneal and deep infiltrating endometriosis. However, peritoneal endometriosis was associated with a twofold increase in risk of endometrioid histology. The risk of endometrial cancer was not altered in the entire cohort. The standardized incidence ratio for precancerous cervical lesions was 0.81 (0.71-0.92) and for invasive squamous cell carcinoma of the cervical cancer 0.46 (0.20-0.91). CONCLUSION: The excess risk of ovarian cancer among women with ovarian endometriosis translates into two excess cases per 1,000 patients followed for 10 years. Acknowledging these risks is important when planning long-term management of women with endometriosis.
引用
- Saavalainen L, Lassus H, But A, et al. Risk of Gynecologic Cancer According to the Type of Endometriosis. Obstet Gynecol. 2018. PMID: 29742675. doi:10.1097/AOG.0000000000002624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。